Citigroup’s Bio-Path Holdings Inc BPTH Stock Holding History

Citigroup’s Portfolio BPTH Stock Details BPTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Hold	0	–	–	–	7525
2017 Q1	–	Sell	-22	Closed	-$79.9K	–	7377
2016 Q4	$120K	Buy	22 +20	+1,000%	+$96.9K	﹤0.01%	5662
2016 Q3	$10K	Hold	2	–	–	﹤0.01%	6547
2016 Q2	$17K	Buy	+2	New	+$20.3K	﹤0.01%	6257
2016 Q1	–	Sell	-1	Closed	-$6.48K	–	7847
2015 Q4	$4K	Buy	+1	New	+$5.83K	﹤0.01%	7134
2015 Q3	–	Hold	0	–	–	–	7798
2015 Q2	–	Sell	-1	Closed	-$5.47K	–	7819
2015 Q1	$7K	Sell	1 -2	-67%	-$16.8K	﹤0.01%	6620
2014 Q4	$34K	Buy	3 +2	+200%	+$20.7K	﹤0.01%	5932
2014 Q3	$5K	Buy	+1	New	+$9.65K	﹤0.01%	6579
2014 Q2	–	Hold	0	–	–	–	6790

Other funds holding BPTH

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RCA

Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup's BPTH Position: Q2 2017 in Review

Citigroup held its Bio-Path Holdings Inc (BPTH) position steady in Q2 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7525.

Citigroup first reported a position in BPTH in Q3 2014 and has held it in 7 quarters since. The position peaked at $120K in Q4 2016. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2017.

Citigroup held 0 shares of Bio-Path Holdings Inc worth $0 as of Q2 2017.
Citigroup left its Bio-Path Holdings Inc share count unchanged in Q2 2017.
Bio-Path Holdings Inc made up ﹤0.01% of Citigroup's portfolio in Q2 2017, its #7525 holding.
Citigroup first reported a position in Bio-Path Holdings Inc in Q3 2014 and has held it in 7 quarters since.
Citigroup's Bio-Path Holdings Inc position peaked at $120K in Q4 2016.
33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.